Lucentis for Macular Edema User Reviews
Lucentis has an average rating of 6.7 out of 10 from a total of 3 reviews for the treatment of Macular Edema. 33% of reviewers reported a positive experience, while 0% reported a negative experience.
- Paul...
- September 10, 2015
"i lost a lot of my vision after injection. Blind spots. Didn't work for me."
- Dan...
- February 18, 2016
"After two days my sight was restored. It was terrific except it did not last more than a few weeks. Had the same experience with Eylea."
Frequently asked questions
- What are biosimilar drugs and how do they compare to biologics?
- What are anti-VEGF drugs (VEGF inhibitors)?
- What biosimilars have been approved in the United States?
- Meg
- January 7, 2017
"7 injections approximately monthly intervals. 8 injection scheduled but not given as edema gone, however, left my eye with dead cone cells. Vision worse than before injections."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Lucentis (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
"My doc started me on Lucentis after I had a reaction to Avastin. My condition improved after 8 months. I also began taking an AREDS vitamin formula in the last two months of treatment and increased the amount of green leafy veggies (Chard, Spinach and Kale) in my diet and stopped my daily baby aspirin (some clinical studies indicate may worsen the condition) So I cannot attribute improvement solely to Lucentis. One thing to be very aware of is the cost. The Medicare co-pay per treatment (per eye) is about $500. "